IL-NIELSENIQ
21.7.2022 13:02:04 CEST | Business Wire | Press release
NielsenIQ is pleased to announce the 2022 recipients of the seventh annual NielsenIQ BASES Design Impact Awards for the consumer-packaged goods (CPG) industry. The global competition recognizes and celebrates best-in-class package redesigns, and the business impacts they make for their companies. This year’s winners include brands that delivered innovative and creative packaging with design concepts that reflected brand vision while supporting the shopper journey.
Sixty brands submitted package redesigns and the NielsenIQ BASES team used the company’s proprietary Retail Measurement Sales (RMS) data to identify which brands demonstrated an increase in sales after the launch of the updated package designs. In addition to evaluating RMS data, NielsenIQ conducted a behavioral survey of 15,000 shoppers to assess individual entries across the shopper journey. Each product was evaluated to determine if it presented a visually appealing, easily identifiable package that allowed consumers to find the product on shelves and engage them to purchase the item. The results unveiled 10 winners across various CPG categories with excellent designs and a measurable increase in sales.
“Our team is thrilled to support and promote inspired brands who deliver fresh, beautifully designed packages that stimulate brand growth and financial successes,” said Andrea Fraboni, Vice President & Global Leader of BASES Design Solutions at NielsenIQ. “This year’s winners embody how effective redesigned packaging can help transform and elevate the bottom line of a brand. These companies did it right and we’re excited to showcase their outstanding accomplishments.”
The winners of the 2022 NielsenIQ BASES Design Impact Award* are:
- L’usine Sliced Multigrain Bread (Parent Company: Almarai; Country: Saudi Arabia)
- Coors Light Beer (Parent Company: Molson Coors Beverage Company; Design Agency: Soulsight; Country: United States)
- Brooke's Oros Beverages (Parent Company: Tiger Brands; Design Agency: Just Design; Country: South Africa)
- Cadbury Old Gold Chocolate (Parent Company: Mondelez International; Design Agency: Bulletproof; Country: Australia)
- Lucozade Energy Drink (Parent Company: Suntory; Country: United Kingdom)
- Nescafé Artesano Coffee (Parent Company: Nestlé; Country: Colombia)
- SSENSE Herbal Tea (Parent Company: SSENSE; Design Agency: Pigeon; Country: Canada)
- Turin Chocolate (Parent Company: Mars; Country: Mexico)
- Speed Stick & Lady Speed Stick (Parent Company: Colgate-Palmolive; Design Agency: Dragon Rouge BZ; Country: Mexico)
- Lay's Potato Chips (Parent Company: PepsiCo; Design Agency: PEP Global Design Team; Country: South Africa)
Learn more about our package design research solutions, the NielsenIQ BASES Design Impact Award, and learnings from this year’s winners by visiting the BASES Design Impact Award web page.
*All products and company names are trademarks of their respective holders. No affiliation or endorsement is expressed or implied.
About NielsenIQ
NielsenIQ, a global information services company, delivers the gold standard in consumer and retail measurement, through the most connected, complete, and actionable understanding of the evolving global, omnichannel consumer. NielsenIQ is the source of confidence for the industries we serve and the pioneer defining the next century of consumer and retail measurement. Our data, connected insights, and predictive analytics optimize the performance of CPG and retail companies, bringing them closer to the communities they serve and helping to power their growth.
NielsenIQ, an Advent International portfolio company, has operations in 90+ markets, covering more than 90% of the world’s population. For more information, visit NielsenIQ.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220721005158/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom